Company Filing History:
Years Active: 1997-1998
Title: Heaok Kim Jeong: Innovator in A3 Adenosine Receptor Agonists
Introduction
Heaok Kim Jeong, located in Rockville, MD, is an accomplished inventor known for his contributions to the field of medicinal chemistry, particularly in the realm of A3 adenosine receptor agonists. With two patents to his name, his work focuses on developing compounds that could potentially provide therapeutic benefits in activating A3 receptors selectively in mammals.
Latest Patents
The latest inventions by Heaok Kim Jeong include groundbreaking patents related to A3 adenosine receptor agonists. One notable patent outlines the creation of N^6-benzyladenosine-5'-N-uronamide and its related substituted compounds. This invention particularly emphasizes pharmaceutical compositions containing these compounds, as well as methods for selectively activating A3 adenosine receptors in mammals. The application claims a method of administering compounds that stimulate an A3 receptor-dependent response, focusing on therapeutic effectiveness.
Another significant patent by Heaok Kim Jeong introduces A3 selective agonists made from adenine compounds featuring selected substituents at specific positions. Similar to his first invention, this patent also provides a method for the selective activation of A3 receptors in mammals, reinforcing the potential for developing advanced therapeutic solutions.
Career Highlights
Heaok Kim Jeong’s career is marked by innovative research and development in the field of pharmaceutical sciences. His work is carried out under the auspices of the United States of America as represented by the Department of Health. His extensive knowledge and skills in medicinal chemistry have been integral to the formulation of new compounds aimed at improving health outcomes through targeted receptor activation.
Collaborations
Heaok Kim Jeong collaborates with distinguished colleagues such as Kenneth Alan Jacobson and Carola Gallo-Rodriguez. Their combined expertise enriches the research environment, fostering an innovative approach to exploring the therapeutic potentials of adenosine receptors. The collaboration highlights the importance of teamwork in advancing scientific discoveries and enhancing the efficacy of new medicinal compounds.
Conclusion
In summary, Heaok Kim Jeong is a pivotal figure in the development of A3 adenosine receptor agonists, with his patents demonstrating a commitment to creating compounds that can greatly enhance therapeutic interventions. His collaborations with esteemed colleagues further underscore the collaborative spirit of innovation in the scientific community. As research in this field continues to evolve, the contributions of Heaok Kim Jeong remain a vital part of the landscape of medical advancements.